Cyclosporin A, tacrolimus and sirolimus are potent inhibitors of the human breast cancer resistance protein (ABCG2) and reverse resistance to mitoxantrone and topotecan.

Saved in:
Bibliographic Details
Title: Cyclosporin A, tacrolimus and sirolimus are potent inhibitors of the human breast cancer resistance protein (ABCG2) and reverse resistance to mitoxantrone and topotecan.
Authors: Gupta A; Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, 98195-7610, USA., Dai Y, Vethanayagam RR, Hebert MF, Thummel KE, Unadkat JD, Ross DD, Mao Q
Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2006 Sep; Vol. 58 (3), pp. 374-83. Date of Electronic Publication: 2006 Jan 11.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0344-5704 (Print) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 16404634
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cyclosporin A, tacrolimus and sirolimus are potent inhibitors of the human breast cancer resistance protein (ABCG2) and reverse resistance to mitoxantrone and topotecan.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gupta+A%22">Gupta A</searchLink>; Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, 98195-7610, USA.<br /><searchLink fieldCode="AU" term="%22Dai+Y%22">Dai Y</searchLink><br /><searchLink fieldCode="AU" term="%22Vethanayagam+RR%22">Vethanayagam RR</searchLink><br /><searchLink fieldCode="AU" term="%22Hebert+MF%22">Hebert MF</searchLink><br /><searchLink fieldCode="AU" term="%22Thummel+KE%22">Thummel KE</searchLink><br /><searchLink fieldCode="AU" term="%22Unadkat+JD%22">Unadkat JD</searchLink><br /><searchLink fieldCode="AU" term="%22Ross+DD%22">Ross DD</searchLink><br /><searchLink fieldCode="AU" term="%22Mao+Q%22">Mao Q</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227806519%22">Cancer chemotherapy and pharmacology</searchLink> [Cancer Chemother Pharmacol] 2006 Sep; Vol. 58 (3), pp. 374-83. <i>Date of Electronic Publication: </i>2006 Jan 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>7806519 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>0344-5704 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203445704%22">03445704 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Chemother Pharmacol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=16404634
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00280-005-0173-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 374
    Titles:
      – TitleFull: Cyclosporin A, tacrolimus and sirolimus are potent inhibitors of the human breast cancer resistance protein (ABCG2) and reverse resistance to mitoxantrone and topotecan.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gupta A
      – PersonEntity:
          Name:
            NameFull: Dai Y
      – PersonEntity:
          Name:
            NameFull: Vethanayagam RR
      – PersonEntity:
          Name:
            NameFull: Hebert MF
      – PersonEntity:
          Name:
            NameFull: Thummel KE
      – PersonEntity:
          Name:
            NameFull: Unadkat JD
      – PersonEntity:
          Name:
            NameFull: Ross DD
      – PersonEntity:
          Name:
            NameFull: Mao Q
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2006 Sep
              Type: published
              Y: 2006
          Identifiers:
            – Type: issn-print
              Value: 0344-5704
          Numbering:
            – Type: volume
              Value: 58
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Cancer chemotherapy and pharmacology
              Type: main
ResultId 1